Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)

OBJECTIVE: To compare efficacy and safety of dulaglutide at doses of 3.0 and 4.5 mg versus 1.5 mg in patients with type 2 diabetes inadequately controlled with metformin. RESEARCH DESIGN AND METHODS: Patients were randomly assigned to once-weekly dulaglutide 1.5 mg, 3.0 mg, or 4.5 mg for 52 weeks. T...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Care
Main Authors: Frias, Juan P., Bonora, Enzo, Nevarez Ruiz, Luis, Li, Ying G., Yu, Zhuoxin, Milicevic, Zvonko, Malik, Raleigh, Bethel, M. Angelyn, Cox, David A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2021
Assuntos:
Emerging Therapies: Drugs and Regimens
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7896253/
https://ncbi.nlm.nih.gov/pubmed/33397768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-1473
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados